Home > Research > Researchers > Anthony Aggidis

Supervised by

Anthony Aggidis

Research student

Anthony Aggidis

Furness Building Lancaster University Bailrigg Lancaster LA1 4YG


United Kingdom

Current Research

Professor David Allsop’s research group, following extensive years of research have recently developed a novel retro-inverted peptide-based amyloid beta aggregation inhibitor that may be useful for treatment of Alzheimer’s disease. Tau aggregation inhibitors are a completely new venture for this research group. For my novel PhD research I am pioneering and developing peptide-based tau aggregation inhibitors, testing their interactions with a variety of tau protein aggregation systems and characterising subsequent structures formed from co-incubation. My successful lead tau aggregation inhibitor may be useful as a potential treatment for Alzheimer's disease and perhaps other tauopathies.

View all (4) »